Hepatitis C treatment is no longer prohibitively expensive in the Global South because Malaysia, Thailand, Egypt and the Drugs for Neglected Diseases initiative developed ravidasvir – a low-cost antiviral. Such breakthroughs are possible for other neglected diseases if low- and middle-income countries agree to act collectively.
A year-long government “sandbox” study identifies recurring conflicts in solar, aquaculture-solar, micro-hydropower and geothermal projects, prompting policy reforms …